Future Market Insights predicts, in 2026, the AI dermatology imaging market is being reshaped by mounting economic pressure on healthcare systems to improve early skin cancer detection while expanding access to specialist-grade diagnostics through cloud-native and smartphone-integrated platforms. Over the 2026 to 2036 period, the industry is expected to evolve from standalone lesion imaging tools toward a connected diagnostic ecosystem, where AI-driven image interpretation, remote screening workflows, and predictive risk stratification become central to routine dermatology care, reducing diagnostic delays and enabling earlier intervention across both clinical and telemedicine settings.